메뉴 건너뛰기




Volumn 20, Issue 11, 2007, Pages 1169-1171

Exogenous Cushing's syndrome induced by surreptitious topical glucocorticosteroid overdose in infants with diaper dermatitis

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; CORTICOTROPIN; DIFLUCORTOLONE VALERATE; GLUCOCORTICOID; HYDROCORTISONE;

EID: 37349000573     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.11.1169     Document Type: Note
Times cited : (5)

References (10)
  • 1
    • 0031953032 scopus 로고    scopus 로고
    • Super potent topical corticosteroid use associated with adrenal suppression: Clinical considerations
    • Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol 1998; 38: 318-321.
    • (1998) J Am Acad Dermatol , vol.38 , pp. 318-321
    • Gilbertson, E.O.1    Spellman, M.C.2    Piacquadio, D.J.3    Mulford, M.I.4
  • 2
    • 0034007934 scopus 로고    scopus 로고
    • Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis
    • Ellison JA, Patel L, Ray DW, David TJ, Clayton PE. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics 2000; 105: 794-799.
    • (2000) Pediatrics , vol.105 , pp. 794-799
    • Ellison, J.A.1    Patel, L.2    Ray, D.W.3    David, T.J.4    Clayton, P.E.5
  • 3
    • 22144466948 scopus 로고    scopus 로고
    • Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function
    • Abraham G, Gottschalk J, Ungemach FR. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology 2005; 146: 3163-3171.
    • (2005) Endocrinology , vol.146 , pp. 3163-3171
    • Abraham, G.1    Gottschalk, J.2    Ungemach, F.R.3
  • 4
    • 29244488112 scopus 로고    scopus 로고
    • Post-marketing safety review - PID D010141
    • Weaver J. Post-marketing safety review - PID D010141. Drugs: Topical corticosteroids. http://www.fda.gov/ohrms/dockets/ac/03/briefing/ 3999B1_21_Weaver-Memo%2007-09-01.pdf.
    • Drugs: Topical corticosteroids
    • Weaver, J.1
  • 6
    • 37349043235 scopus 로고    scopus 로고
    • Cushing's syndrome and adrenal insufficiency caused by topical steroids: Misuse or abuse?
    • Güven A, Gülümser Ö, Özgen T. Cushing's syndrome and adrenal insufficiency caused by topical steroids: misuse or abuse? J Pediatr Endocrinol Metab 2007; 20: 1173-1182.
    • (2007) J Pediatr Endocrinol Metab , vol.20 , pp. 1173-1182
    • Güven, A.1    Gülümser, O.2    Özgen, T.3
  • 7
    • 0034160018 scopus 로고    scopus 로고
    • The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis
    • Beishuizen A, van Lijf JH, Lekkerkerker JF, Vermes I. The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Neth J Med 2000; 56: 91-99.
    • (2000) Neth J Med , vol.56 , pp. 91-99
    • Beishuizen, A.1    van Lijf, J.H.2    Lekkerkerker, J.F.3    Vermes, I.4
  • 10
    • 0032011291 scopus 로고    scopus 로고
    • The artful use of topical steroids
    • Brodkin RH, Janniger CK. The artful use of topical steroids. Cutis 1998; 61: 125-126.
    • (1998) Cutis , vol.61 , pp. 125-126
    • Brodkin, R.H.1    Janniger, C.K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.